Age (yrs) |
60.3 ± 11.4 |
Male |
38 (60.3) |
LVEF (%) |
59.3 ± 7.5 |
LA diameter (mm) |
4.4 ± 0.6 |
Height (cm) |
173.8 ± 11.7 |
Weight (kg) |
91.3 ± 17.5 |
Resting Heart Rate (bpm) |
72.2 ± 17.6 |
Resting Systolic Blood Pressure (mmHg) |
142.5 ± 17.6 |
Resting Diastolic Blood Pressure (mmHg) |
82.6 ± 10.1 |
Hemoglobin (g/l) |
140 ± 33.5 |
Creatinine (µmol/l) |
88.5 ± 17.8 |
Glomerular Filtration Rate (ml/min/1.73m2) |
77.1 ±
19 |
AF duration (months) |
40.5 ± 34.6 |
Hypertension |
45 (71.4) |
Heart failure |
2 (3.2) |
Diabetes mellitus |
7 (11.1) |
Stroke |
5 (7.9) |
CAD |
6 (9.5) |
CHA2DS2-VASc |
1,8 ± 1,2 |
Antiarrhythmic Therapy |
|
Class I |
33 (52.4) |
Class II |
26 (41.3) |
Class III |
14 (22.2) |
Class IV |
0 (0) |
Anticoagulation/Antiagregation Therapy |
|
Vitamin K Antagonist |
17 (27) |
Direct Oral Anticoagulants |
36 (57.1) |
Acetylsalicylic Acid |
4 (6.4) |
Values are mean ± SD or n (%); AF = atrial fibrillation; CAD = coronary
artery disease; LA = left atrial; LVEF = left ventricular ejection
fraction. |
Values are mean ± SD or n (%); AF = atrial fibrillation;
CAD = coronary artery disease; LA = left atrial; LVEF = left ventricular
ejection fraction. |